Related Experiment Video
Updated: Jun 12, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
305
Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis
Qianyu Wang1, Gang Pan2, Yu Zhang2
1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.
Human Vaccines & Immunotherapeutics
|September 19, 2024
Summary
Research on thyroid cancer immunotherapy is rapidly expanding, with China leading publications. Key areas include immune checkpoint inhibitors and combination therapies, highlighting innovative treatment potential.
Area of Science:
- Endocrinology
- Oncology
- Immunology
Background:
- Thyroid cancer is a significant endocrine malignancy with challenging treatment for aggressive forms.
- Immunotherapy has emerged as a powerful strategy in cancer treatment, showing recent advancements.
Purpose of the Study:
- To analyze the publication landscape of thyroid cancer immunotherapy.
- To identify research trends, key institutions, and influential authors in the field.
Main Methods:
- Bibliometric analysis and visualization tools were employed.
- Data sourced from the Web of Science Core Collection (WoSCC).
- 409 articles published on thyroid cancer immunotherapy were included.
Main Results:
- A consistent annual increase in publications and citations since 2016.
- China leads in research output; University of Texas System and UTMD Anderson Cancer Center are top institutions.
- The journal 'Thyroid' received the most citations; notable authors identified.
Conclusions:
- Research hotspots include immune checkpoint inhibitors, combination therapies, CAR-T cell therapy, and tumor microenvironment modulation.
- These findings indicate a dynamic field with potential for novel thyroid cancer treatments.
Related Concept Videos
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
01:27Cytotoxic T Cells-mediated Immune Response
858
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
858
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K